116 related articles for article (PubMed ID: 23157678)
1. Understanding respiratory syncytial virus infection to improve treatment and immunity.
González PA; Carreño LJ; Bueno SM; Riedel CA; Kalergis AM
Curr Mol Med; 2013 Aug; 13(7):1122-39. PubMed ID: 23157678
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus infection and immunity.
González PA; Bueno SM; Carreño LJ; Riedel CA; Kalergis AM
Rev Med Virol; 2012 Jul; 22(4):230-44. PubMed ID: 22290692
[TBL] [Abstract][Full Text] [Related]
3. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.
González PA; Bueno SM; Riedel CA; Kalergis AM
Curr Med Chem; 2009; 16(34):4609-25. PubMed ID: 19903147
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response.
Hoffman SJ; Laham FR; Polack FP
Microbes Infect; 2004 Jul; 6(8):767-72. PubMed ID: 15207824
[TBL] [Abstract][Full Text] [Related]
5. Local cytokine response upon respiratory syncytial virus infection.
Bueno SM; González PA; Riedel CA; Carreño LJ; Vásquez AE; Kalergis AM
Immunol Lett; 2011 May; 136(2):122-9. PubMed ID: 21195729
[TBL] [Abstract][Full Text] [Related]
6. Host immunity during RSV pathogenesis.
Bueno SM; González PA; Pacheco R; Leiva ED; Cautivo KM; Tobar HE; Mora JE; Prado CE; Zúñiga JP; Jiménez J; Riedel CA; Kalergis AM
Int Immunopharmacol; 2008 Oct; 8(10):1320-9. PubMed ID: 18687294
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.
Welliver TP; Reed JL; Welliver RC
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S92-6. PubMed ID: 18820587
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses.
Mebratu YA; Smith KR; Agga GE; Tesfaigzi Y
Respir Res; 2016 Jul; 17(1):75. PubMed ID: 27363862
[TBL] [Abstract][Full Text] [Related]
9. The role of Th17 and Treg responses in the pathogenesis of RSV infection.
Mangodt TC; Van Herck MA; Nullens S; Ramet J; De Dooy JJ; Jorens PG; De Winter BY
Pediatr Res; 2015 Nov; 78(5):483-91. PubMed ID: 26267154
[TBL] [Abstract][Full Text] [Related]
10. Human Respiratory Syncytial Virus: An Introduction.
Jorquera PA; Anderson L; Tripp RA
Methods Mol Biol; 2016; 1442():1-12. PubMed ID: 27464683
[TBL] [Abstract][Full Text] [Related]
11. Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.
Lee YT; Kim KH; Hwang HS; Lee Y; Kwon YM; Ko EJ; Jung YJ; Lee YN; Kim MC; Kang SM
Virology; 2015 Nov; 485():36-46. PubMed ID: 26196232
[TBL] [Abstract][Full Text] [Related]
12. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis.
García C; Soriano-Fallas A; Lozano J; Leos N; Gomez AM; Ramilo O; Mejias A
Pediatr Infect Dis J; 2012 Jan; 31(1):86-9. PubMed ID: 21829141
[TBL] [Abstract][Full Text] [Related]
13. Experimental animal model for analyzing immunobiological responses following vaccination with formalin-inactivated respiratory syncytial virus.
Sawada A; Nakayama T
Microbiol Immunol; 2016 Apr; 60(4):234-42. PubMed ID: 26865035
[TBL] [Abstract][Full Text] [Related]
14. Immunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus.
Vandini S; Bottau P; Faldella G; Lanari M
Biomed Res Int; 2015; 2015():875723. PubMed ID: 26064963
[TBL] [Abstract][Full Text] [Related]
15. Determinants of host susceptibility to murine respiratory syncytial virus (RSV) disease identify a role for the innate immunity scavenger receptor MARCO gene in human infants.
High M; Cho HY; Marzec J; Wiltshire T; Verhein KC; Caballero MT; Acosta PL; Ciencewicki J; McCaw ZR; Kobzik L; Miller-DeGraff L; Gladwell W; Peden DB; Serra ME; Shi M; Weinberg C; Suzuki O; Wang X; Bell DA; Polack FP; Kleeberger SR
EBioMedicine; 2016 Sep; 11():73-84. PubMed ID: 27554839
[TBL] [Abstract][Full Text] [Related]
16. Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice.
Remot A; Descamps D; Jouneau L; Laubreton D; Dubuquoy C; Bouet S; Lecardonnel J; Rebours E; Petit-Camurdan A; Riffault S
Eur J Immunol; 2016 Apr; 46(4):874-84. PubMed ID: 26681580
[TBL] [Abstract][Full Text] [Related]
17.
van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
[TBL] [Abstract][Full Text] [Related]
18. Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice.
Boelen A; Andeweg A; Kwakkel J; Lokhorst W; Bestebroer T; Dormans J; Kimman T
Vaccine; 2000 Nov; 19(7-8):982-91. PubMed ID: 11115725
[TBL] [Abstract][Full Text] [Related]
19. Functional disorder of primary immunity responding to respiratory syncytial virus infection in offspring mice exposed to a flame retardant, decabrominated diphenyl ether, perinatally.
Watanabe W; Shimizu T; Sawamura R; Hino A; Konno K; Kurokawa M
J Med Virol; 2010 May; 82(6):1075-82. PubMed ID: 20419825
[TBL] [Abstract][Full Text] [Related]
20. In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus.
Kim JY; Chang J
Yonsei Med J; 2016 Jul; 57(4):809-16. PubMed ID: 27189271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
